Altered release of endothelium-derived relaxing factor/nitric oxide (E
DRF/NO) has been proposed as a final common pathway underlying the abn
ormal vasodilator responses to gram-negative lipopolysaccharide (endot
oxin). However, mechanisms responsible for lipopolysaccharide-induced
changes in EDRF/NO release from endothelial cells have not been clarif
ied. We evaluated direct effects of Escherichia coli endotoxin on agon
ist-stimulated cytosolic Ca2+ mobilization and NO biosynthesis in cult
ured bovine and porcine aortic endothelial cells (ECs). Two methods we
re used to assay for NO: (1) analysis of NO-induced endothelial levels
of cGMP as a biological indicator of NO generation and (2) direct qua
ntitative measurement of NO release (chemiluminescence method). Cytoso
lic free Ca2+ ([Ca2+]i) was evaluated using fura 2 fluorescence method
ology (340/380-nm ratio excitation and 500-nm emission). Incubation of
ECs with endotoxin (0.5 mu g/mL, 1 hour plus 1-hour wash) significant
ly inhibited bradykinin (100 nmol/L)- and ADP (10 mu mol/L)-mediated i
ncreases in endothelial cell cGMP to 37% and 22% of control responses,
respectively. In contrast, endotoxin failed to inhibit the increase i
n cGMP produced by the non-receptor-dependent Ca2+ ionophore A23187 (1
mu mol/L) or sodium nitroprusside (1 mmol/L). Similarly, incubation w
ith endotoxin inhibited ADP-stimulated increases in NO release and EDR
F bioactivity to 55% and 56% of control values, respectively, but did
not affect A23187-stimulated increases in NO release or EDRF bioactivi
ty. Endotoxin produced significant decreases in both transient and sus
tained [Ca2+](i) responses of ECs to bradykinin and ADP. For example,
the initial rapid increase in bovine EC [Ca2+](i) in response to brady
kinin was reduced to 31% of the initial increases in control cells, an
d the secondary plateau phase was reduced to only 3% of respective con
trol responses. Concentration-response relation to endotoxin (10(-3) t
o 100 mu g/mL) indicated high correlation and similar IC50 values (0.0
25 and 0.021 mu g/mL, respectively) for inhibitory effects on cGMP and
[Ca2+](i). Endotoxin had no effect on inositol trisphosphate formatio
n ([H-3]myo-inositol incorporation) and intracellular Ca2+ release ([C
a2+](i) responses in Ca2+-free medium) induced by bradykinin. However,
agonist-stimulated Mn2+ quenching (index of Ca2+ influx) was signific
antly attenuated by endotoxin treatment. These studies demonstrate tha
t endotoxin directly decreases agonist (bradykinin and ADP)-mediated b
iosynthesis and release of EDRF/NO from ECs. These effects can be expl
ained by altered [Ca2+](i) mobilization mechanisms, which in turn prod
uce subsequent decreases in activity of the Ca2+-calmodulin-dependent
constitutive isoform of NO synthase and, ultimately, impairment of ago
nist-mediated NO release and endothelium-dependent vasodilation.